
- FDA status
- Compounded; not FDA-approved
- 503A status
- Category 1 (under evaluation), May 2026
- Long-term safety data
- None
- HealifyMD form and price
- Subcutaneous injection, from $199/month
Three separate safety questions
When people ask whether NAD+ injections are safe, they're usually asking three things at once. What will I feel after a dose? Is there anyone who shouldn't have it? And how sure can I be about the product and the long-term picture? The answers are quite different for each.
What you might feel after a dose
With subcutaneous injections, the kind HealifyMD prescribes, the most commonly described effects are:
In practice, that means most people experience NAD+ injections as a minor nuisance rather than a danger, while acknowledging that the long-term record simply hasn't been written yet.
- Redness, stinging or tenderness where the needle went in.
- Flushing or a feeling of warmth.
- Nausea.
- Headache or lightheadedness.
- Stomach cramping or chest tightness, which some people report with larger or faster doses.
What the research does and doesn't show
Human data on injected NAD+ are sparse. One of the few published studies, a 2019 pilot in Frontiers in Aging Neuroscience, gave eight healthy men 750 mg of NAD+ by IV over six hours and compared them with three men given saline. No adverse events were reported during the infusion, and small changes in some liver enzymes were judged not clinically significant. Blood NAD+ rose substantially only toward the end of the infusion, suggesting the body clears it quickly.
That's reassuring as far as it goes, but it's a tiny, short study of IV infusion in healthy men, partly funded by a company with a commercial interest in IV NAD+. It doesn't tell us about subcutaneous injections, women, older adults, people with chronic illness, or repeated use over months and years. It also didn't test whether people felt or functioned better.
Until larger and longer studies exist, it's reasonable to treat NAD+ injections as an experiment you run carefully, with a clear reason, a defined review point and a willingness to stop.
Who should avoid it or check first
- Pregnancy or breastfeeding: safety hasn't been established.
- Active or recent cancer: NAD+ is involved in cell metabolism and DNA repair, so your oncology team should weigh in. This is caution, not evidence of harm.
- Significant kidney or liver disease.
- A previous bad reaction to NAD+.
- Complex medication regimens, which your clinician should review first.
Where much of the real risk sits: the product
NAD+ injections are compounded. They are not FDA-approved, FDA doesn't verify their safety, effectiveness or quality before they're dispensed, and they aren't equivalent to any approved drug. FDA's nominations list for 503A compounding, updated in May 2026, places NAD in Category 1, meaning it's still under evaluation rather than formally accepted or rejected.
That makes the source important. A prescription filled by a licensed U.S. pharmacy, with a clinician who knows your history, is a very different proposition from a product bought online with no clear origin. Any injectable also needs sterile handling; follow your pharmacy's storage instructions and never reuse needles.
What isn't established yet
- Long-term safety of repeated injections over months or years.
- Interactions with other medicines, which haven't been formally studied.
- A lab test that shows whether you need NAD+, whether it's working, or whether you're getting too much.
- Clinical benefits such as more energy or slower aging, which haven't been demonstrated in rigorous human trials.
Why 'natural' doesn't settle the question
NAD+ is a molecule every cell already makes, which leads some marketing to describe injections as inherently safe. But the amount, route and frequency matter. Your body normally makes and recycles NAD+ inside cells; an injection delivers a concentrated dose from outside, much of which is rapidly broken down into related compounds such as nicotinamide.
Being natural to the body also doesn't tell you anything about the purity of a specific vial, or about how repeated doses interact with your particular health conditions and medicines. Those are the questions that clinical studies and product quality controls answer, and for NAD+ injections, those answers are still incomplete.
How to make treatment as safe as possible
Practical steps matter more than any single claim of safety. Start with a full review of your medications, supplements and health history. Use a product from a licensed pharmacy, follow the dose your clinician sets, and agree on a time to review whether it's worth continuing. Report side effects rather than pushing through them, since a dose or schedule change often helps.
If you feel chest pain, trouble breathing, swelling of the face or throat, or fainting, seek emergency care.
NAD+ at HealifyMD
HealifyMD's NAD+ Injection is a subcutaneous injection listed from $199/month, with pricing confirmed at your eligibility review. Ongoing follow-up with your clinician is included, so you have a route to report side effects and reassess.
Common questions
Is an NAD+ injection safe?
Short-term side effects are usually mild and pass, but long-term safety hasn't been studied, and the product is compounded rather than FDA-approved.
What does it feel like?
Many people feel a brief sting and sometimes flushing, warmth or mild nausea afterward. Larger doses are more likely to cause discomfort.
Is NAD+ FDA-approved?
No. NAD+ injections are compounded. FDA lists NAD in Category 1 of nominated 503A bulk substances, meaning it's still under evaluation.
Who should not have NAD+ injections?
People who are pregnant or breastfeeding should avoid them. Those with active cancer or significant kidney or liver disease need specialist input first.
Can I have too much NAD+?
There's no established upper limit or blood test to guide this, which is why your clinician sets the dose and reviews it over time.
Are IV drips safer than injections?
Not necessarily. IV infusions deliver larger amounts and need clinical monitoring; side effects like nausea and chest tightness are often linked to infusion speed.
Does NAD+ cause cancer?
There's no evidence that it does. The caution in cancer reflects NAD+'s role in cell metabolism and the lack of studies, not a known harm.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated May 2026)U.S. Food and Drug Administration
- A pilot study of changes in the human plasma and urine NAD+ metabolome during a 6-hour intravenous infusion of NAD+ (2019)Frontiers in Aging Neuroscience
- Niacin: Fact Sheet for Health ProfessionalsNIH Office of Dietary Supplements